Content by Mallinckrodt Pharmaceuticals
Mallinckrodt will acquire Questcor for approximately $5.6 Billion, creating a diversified, high-growth specialty pharmaceuticals company.
| 5 min read
Page 1 of 1 - 1 Total Items
CURRENT ISSUE - March 2025
Driving Lab Success Through Continuous Improvement
Embrace nonconforming work as opportunities for growth and improved lab performance
